TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial.

Kevin W Garey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.